We serve Chemical Name:trimethylolpropane tris[poly(propylene glycol), amine terminated] ether CAS:39423-51-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:trimethylolpropane tris[poly(propylene glycol), amine terminated] ether
CAS.NO:39423-51-3
Synonyms:MFCD00197951
Molecular Formula:(C3H6O)n(C3H6O)n(C3H6O)nC15
Molecular Weight:N/A
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:0.981 g/mL at 25 °C(lit.)
Index of Refraction:n20/D 1.461(lit.)
PSA:
Exact Mass:
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3267 8/PG 3
Packing Group:II
Contact us for information like MFCD00197951 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00197951 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00197951 Use and application,MFCD00197951 technical grade,usp/ep/jp grade.
Related News: Citizens and residents will be allowed entry to New Zealand, but will be required to quarantine themselves for 14 days, Prime Minister Jacinda Ardern said. trimethylolpropane tris[poly(propylene glycol), amine terminated] ether manufacturer In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances. trimethylolpropane tris[poly(propylene glycol), amine terminated] ether supplier Aduhelm, however, is in a different league in terms of the number of potential patients and cost to the healthcare system. trimethylolpropane tris[poly(propylene glycol), amine terminated] ether vendor Aduhelm, however, is in a different league in terms of the number of potential patients and cost to the healthcare system. trimethylolpropane tris[poly(propylene glycol), amine terminated] ether factory In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.